These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


292 related items for PubMed ID: 23365634

  • 1. Genistein sensitizes bladder cancer cells to HCPT treatment in vitro and in vivo via ATM/NF-κB/IKK pathway-induced apoptosis.
    Wang Y, Wang H, Zhang W, Shao C, Xu P, Shi CH, Shi JG, Li YM, Fu Q, Xue W, Lei YH, Gao JY, Wang JY, Gao XP, Li JQ, Yuan JL, Zhang YT.
    PLoS One; 2013; 8(1):e50175. PubMed ID: 23365634
    [Abstract] [Full Text] [Related]

  • 2. ATM- and NEMO-dependent ELKS ubiquitination coordinates TAK1-mediated IKK activation in response to genotoxic stress.
    Wu ZH, Wong ET, Shi Y, Niu J, Chen Z, Miyamoto S, Tergaonkar V.
    Mol Cell; 2010 Oct 08; 40(1):75-86. PubMed ID: 20932476
    [Abstract] [Full Text] [Related]

  • 3. Synergistic antitumour effects of triptolide plus 10-hydroxycamptothecin onbladder cancer.
    Wang T, Ding Y, Yang Y, Wang Z, Gao W, Li D, Wei J, Sun Y.
    Biomed Pharmacother; 2019 Jul 08; 115():108899. PubMed ID: 31063955
    [Abstract] [Full Text] [Related]

  • 4. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
    De Bacco F, Luraghi P, Medico E, Reato G, Girolami F, Perera T, Gabriele P, Comoglio PM, Boccaccio C.
    J Natl Cancer Inst; 2011 Apr 20; 103(8):645-61. PubMed ID: 21464397
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The ATM protein is required for sustained activation of NF-kappaB following DNA damage.
    Piret B, Schoonbroodt S, Piette J.
    Oncogene; 1999 Apr 01; 18(13):2261-71. PubMed ID: 10327072
    [Abstract] [Full Text] [Related]

  • 10. Genistein induces G2/M cell cycle arrest and apoptosis of human ovarian cancer cells via activation of DNA damage checkpoint pathways.
    Ouyang G, Yao L, Ruan K, Song G, Mao Y, Bao S.
    Cell Biol Int; 2009 Dec 01; 33(12):1237-44. PubMed ID: 19732843
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. ATM mediates constitutive NF-kappaB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia.
    Grosjean-Raillard J, Tailler M, Adès L, Perfettini JL, Fabre C, Braun T, De Botton S, Fenaux P, Kroemer G.
    Oncogene; 2009 Feb 26; 28(8):1099-109. PubMed ID: 19079347
    [Abstract] [Full Text] [Related]

  • 13. Increased expression of DNA repair gene XPF enhances resistance to hydroxycamptothecin in bladder cancer.
    Li J, Zhang J, Liu Y, Ye G.
    Med Sci Monit; 2012 Apr 26; 18(4):BR156-62. PubMed ID: 22460090
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice.
    Shanmugam MK, Rajendran P, Li F, Nema T, Vali S, Abbasi T, Kapoor S, Sharma A, Kumar AP, Ho PC, Hui KM, Sethi G.
    J Mol Med (Berl); 2011 Jul 26; 89(7):713-27. PubMed ID: 21465181
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Persistence of unrepaired DNA double strand breaks caused by inhibition of ATM does not lead to radio-sensitisation in the absence of NF-κB activation.
    Veuger SJ, Durkacz BW.
    DNA Repair (Amst); 2011 Feb 07; 10(2):235-44. PubMed ID: 21144805
    [Abstract] [Full Text] [Related]

  • 20. PLK1 is a critical determinant of tumor cell sensitivity to CPT11 and its inhibition enhances the drug antitumor efficacy in squamous cell carcinoma models sensitive and resistant to camptothecins.
    Zuco V, De Cesare M, Zaffaroni N, Lanzi C, Cassinelli G.
    Oncotarget; 2015 Apr 20; 6(11):8736-49. PubMed ID: 25826089
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.